Evidence map›Paper›PMID 27916977›Full record

ReviewNature reviews. Immunology2017

Human immune system variation.

Petter Brodin, Mark M Davis

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05174624 (The Healthy Human Global Project - Hong Kong), which is not on this map. Cited by 362 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
362citing papers in PubMed, 1 pooled it
43.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05174624 completednot on this mapstarted 2022, after this paper: background citation

The Healthy Human Global Project - Hong Kong: A Community-based Cross-sectional Study on Genetic and Environmental Determinants of Immune Phenotype Variance in a Healthy Asian Population - Establishing a Path Towards Personalized Medicine

TypeobservationalSponsorCentre for Immunology & InfectionRan2022 to 2023Enrolled1,026ConditionsHealthy, Immune System and Related DisordersArmsNo intervention
3 · Its place in the literature

Who cites it

362 citing papers in PubMed, 1 synthesis or guideline pooled it, 720 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Use ofFrontiers in immunology · 2023
    Trial
  4. Trial
  5. Article
  6. Unveiling the Immune Mechanisms of Hypertension With Single-Cell Transcriptome-Wide Mendelian Randomization.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Immune development in early life.Nature immunology · 2026
    Review
  16. Article
  17. Article
  18. Biological multi-omics approaches to next-generation biomarkers in immune-related disorders and malignancies: An overview.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  19. Article
  20. Aging restricts maturation of CXCL13bioRxiv : the preprint server for biology · 2026
    Article

302 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Petter BrodinScience for Life Laboratory, Department of Medicine, Solna, Karolinska Institutet, Stockholm 17165, Sweden.
Mark M DavisDepartment of Microbiology and Immunology, Stanford University School of Medicine.
Institute of Infection and Immunity · CAScience for Life Laboratory · SE

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2010 to 2015
$17.3M
Howard Hughes Medical InstituteNIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI090019
6 · The paper itself

Abstract

The human immune system is highly variable between individuals but relatively stable over time within a given person. Recent conceptual and technological advances have enabled systems immunology analyses, which reveal the composition of immune cells and proteins in populations of healthy individuals. The range of variation and some specific influences that shape an individual's immune system is now becoming clearer. Human immune systems vary as a consequence of heritable and non-heritable influences, but symbiotic and pathogenic microbes and other non-heritable influences explain most of this variation. Understanding when and how such influences shape the human immune system is key for defining metrics of immunological health and understanding the risk of immune-mediated and infectious diseases.

Indexed as

HumansImmune System

Identifiers

PMID27916977
PMCPMC5328245
OpenAlexW2560758606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.